Search - tctmd.com

Displaying 461 - 480 of 1230

Sort: Relevancy | Date

Presentation

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

Presenter: Sanjit S. Jolly

July 13, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Industry News

Thoratec Receives CE Mark Approval For HeartMate PHP™

July 13, 2015

News Daily News

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

Todd Neale

July 13, 2015

News Daily News

FDA批准了一种具有生存优势的心力衰竭药物

Todd Neale

July 13, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

Presentation

Stress Testing in the Cath Lab: Assessing Coronary Hemodynamic Significance

Presenter: Habib Samady

July 11, 2015

Presentation

Robotic PCI: The Future Is Here

Presenter: Giora Weisz

July 11, 2015

Presentation

Cath-Lab of The Future

Presenter: Giora Weisz

July 11, 2015

Presentation

Hazards in the Cath Lab: Is Robotic-Assited PCI the Answer?

Presenter: Ryan Reeves

July 11, 2015

News Daily News

房颤患者过渡治疗无法预防血栓栓塞，且会增加出血

Yael L. Maxwell

July 10, 2015

News Daily News

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

Yael L. Maxwell

July 10, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Industry News

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

July 09, 2015

News Industry News

Biotronik launches CRT in women study

July 08, 2015

News Industry News

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

July 07, 2015

Advertisement

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

肺栓塞发作后，二级抗凝效果未持续

Thoratec Receives CE Mark Approval For HeartMate PHP™

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

FDA批准了一种具有生存优势的心力衰竭药物

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

Stress Testing in the Cath Lab: Assessing Coronary Hemodynamic Significance

Robotic PCI: The Future Is Here

Cath-Lab of The Future

Hazards in the Cath Lab: Is Robotic-Assited PCI the Answer?

房颤患者过渡治疗无法预防血栓栓塞，且会增加出血

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

Biotronik launches CRT in women study

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content